Ziwen Zhu

5PUBLICATIONS
50CO-AUTHORS
Neural engineeringMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Medical devicesSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 06, 2026
MIF-mediated reprogramming of myeloid lineage within the glioma tumor microenvironment impacts the efficacy of immune stimulatory gene therapy.

Ziwen Zhu, Noah C Kanis, Anthony E George

|Nov 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene Therapy.

Brandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb

|Jul 03, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas.

Maria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee

|Jan 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance.

Stephen V Carney, Kaushik Banerjee, Anzar Mujeeb

|Jul 23, 2020
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours.

Ziwen Zhu, Abhinav Achreja, Noah Meurs

Pageof 1